Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UCB Board/Management Information 2017

Mar 24, 2017

4017_rns_2017-03-24_f102f129-daf2-4710-8532-8c0b903dbf32.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Viviane Monges

Viviane Monges is a Senior Global Finance Executive who had a diverse and international career mostly in the Pharmaceutical industry.

Viviane started her career in Venezuela with Renault and in Hong Kong with the French News Agency where she was Finance Head for Asia Pacific. She focused then her career in the Pharmaceutical industry, joining Wyeth Pharmaceuticals in 1997 where she held several leadership roles, including CFO for Europe Region and CFO of the Global Pharma business unit. During that time she participated in the geographic expansion in Europe as well as the launch of several key products such as Effexor, Enbrel and Tazocin.

From 2006 to 2010, Viviane was with Novartis OTC, as Europe CFO, then as Global Division CFO. In 2010, she joined Galderma, a Specialty Multinational Dermatology Company, later acquired by Nestlé. As Group CFO she contributed to a fast growth several significant major acquisitions. She is currently CFO of the Nestlé Business Excellence Division at Nestlé, which has responsibility for all Group Shared Services, driving a major Transformation project for the Group, focused on Business Solutions, Processes and Efficiency.

Viviane graduated from Ecole Supérieure de Commerce de Paris.

She is member of the Strategic Board of Neomedlight. She is French, lives in Lausanne with her husband Mathieu and has a great family of 5 children.